Which should you choose? Here's what you need to know.
Tirzepatide is FDA-approved with strong clinical evidence for major weight loss. AOD-9604 is a GH fragment that showed promise in the lab but failed to prove effective in large human trials.
AOD-9604 is a synthetic fragment of growth hormone (amino acids 177-191) studied for stimulating fat breakdown. It has a safe side effect profile but its largest trial didn't achieve significant weight loss.
Choose AOD-9604 if:
You specifically want a fat metabolism approach without appetite suppression or GI side effects, and accept the weaker evidence.
Tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 agonist with FDA approval and clinical data showing up to 22.5% body weight reduction over 72 weeks.
Choose Tirzepatide if:
You want clinically proven, FDA-approved weight loss backed by robust trial data.
Once you've decided which peptide fits your needs, here's how they compare on price and vendor options.
Our top-rated vendor for each, based on trust scores, purity testing, and price.
We re-check vendor prices continuously and score vendors on Finnrick blind-test results — samples bought anonymously and sent to a lab, not vendor claims. No vendor can pay to rank higher. See our full methodology.